| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.3M | -2.7% |
| Cost of Revenue | $90.1M | +64.9% |
| Gross Profit | -$31.8M | -707.5% |
| R&D Expense | $8.2M | +108.4% |
| SG&A Expense | $73.4M | +109.8% |
| Operating Income | -$193.3M | -451.2% |
| Interest Expense | $3.4M | +183.3% |
| Pre-tax Income | -$188.3M | -482.9% |
| Income Tax | $23K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -13.0% |
| Short-term Investments | $460K | -99.0% |
| Accounts Receivable | $1.1M | -69.4% |
| Inventory | $21.4M | +4.4% |
| Current Assets | $44.9M | -48.2% |
| Total Assets | $69.7M | -61.7% |
| Current Liabilities | $70.6M | +62.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.0M | -138.9% |
| Capital Expenditures | $8.1M | +266.4% |
| Investing Cash Flow | -$2.3M | +97.8% |
| Financing Cash Flow | $72.8M | -47.6% |
| Free Cash Flow | -$80.2M | -147.6% |
| -8.0% |
| Net Income | -$188.2M | -479.6% |
| Long-term Debt |
| $407K |
| -63.0% |
| Total Liabilities | $78.7M | +76.4% |
| Stockholders' Equity | -$9.3M | -106.8% |